Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compliance, efficacy and satisfaction with two deferasirox formulations in transfusion-dependent beta-thalassemia
IRCT2015101218603N2Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of deferasirox in beta thalassemia major, beta thalassemia and iron overload (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Compliance with deferasirox formulations, Efficacy of deferasirox formulations and 1 more. Started Dec 2015; status: completed.
02
Drugs
deferasirox
03
Conditions
beta thalassemia majorbeta thalassemiairon overload
Beyond the preview
Go deeper on IRCT2015101218603N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015101218603N2.